Exact Sciences Cuts Q4 Loss on Reduce Costs | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences reported after the close of the market yesterday that its fourth-quarter net loss shrunk by nearly half on reduced spending.

The Marlborough, Mass.-based molecular diagnostics developer brought in license fees of $338,000 for the quarter compared to $337,000 in license fees for the fourth quarter of 2007. The fourth quarter of 2007 also included product sales of $6,000 compared to none for Q4 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.